StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)

Close on Nov 17, 2026Market cap $22.68MP/E –Yield –

How the market prices CervoMed

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

CervoMed trades at 68.5× its earnings, against a median of 10.0× since 2016 — dearer than 93% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2016

Median 10.0×, today 68.5×

What CervoMed keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Operating margin-9407.0%vs -42.9%
EBITDA margin-9407.0%vs -29.3%
Net margin-9160.9%vs -39.9%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity-107.6%vs -53.5%
Return on assets-94.7%vs -40.7%

How hard the assets work

Revenue per dollar of assets0.01vs 0.39
Revenue per employee$22.09Kvs $405.05K
Profit per employee-$2.02Mvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $24.90M.

Cash and short-term investments$24.90M
EBITDA, trailing twelve months-$31.16M

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

-5.50
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

1 of 9 tests passed

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield-133.8%vs -22.8%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

$1.2752-week low52-week high$10.00
$1.5020-day50-day200-day

The close sits 3% of the way up the 52-week range, 85.0% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

35
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

CRVOS&P 500
PeriodCRVOS&P 500DifferenceCRVO per yearS&P 500 per year
1 month-33.0%-4.0%−29.0 pts
3 months-42.5%-5.0%−37.6 pts
Year to date-81.0%+8.2%−89.3 pts
1 year-81.7%+11.2%−92.9 pts
3 years-84.8%+68.5%−153.3 pts-46.6%+19.0%
5 years-94.9%+67.3%−162.2 pts-44.9%+10.8%
10 years-100.0%+291.6%−391.6 pts-55.1%+14.6%

How much it moves

Volatility, 1 year121.7%vs 80.5%
Volume against its 90-day average0.74vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M CRVO shares were sold short on Oct 30, 2026, up 0.4% from the previous report, or 12.71% of the shares available to trade. At recent volumes it would take 4.7 days to buy them back. Over the last 20 sessions, 58.5% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float12.7%vs 8.89%
Short interest as a share of all shares8.02%vs 6.30%
Days of volume to buy it back4.65vs 5.13

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,212,655+0.4%260,5944.7
Oct 15, 20261,208,132-9.8%408,3703.0
Sep 30, 20261,339,771+9.1%189,9577.0
Sep 15, 20261,227,918-7.7%171,8487.2
Aug 31, 20261,329,643+38.1%274,3884.8
Aug 14, 2026962,576+15.6%413,5852.3
Jul 31, 2026832,425+0.6%305,9022.7
Jul 15, 2026827,455+2.5%806,3371.0
Jun 30, 2026807,562+134.9%32,172,2251.0
Jun 15, 2026343,846+30.8%1,017,5001.0
May 29, 2026262,806-5.4%92,0352.9
May 15, 2026277,897-1.4%50,5045.5

Every measure, in full

63 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 16, 2027 (estimated, after the close)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 17, 2026

Valuation ratiosIndustry

Market Cap
$22.68M
$254.69M
Enterprise Value
-$2.22M
$130.88M
PS Ratio
68.45
3.66
PB Ratio
0.99
1.99
P/TBV Ratio
0.99
2.23

Enterprise valuationIndustry

EV / Sales
-6.71
2.38

Share statisticsIndustry

Shares Change (YoY)
8.41%
11.0%
Shares Change (QoQ)
46.1%
0.57%
Float
10M
49M
Shares Held by Insiders
36.9%
11.3%
Shares Held by Institutions
11.6%
56.3%

Short sellingIndustry

Short Interest
1M
–
Short Interest Change
0.37%
-0.80%
Short % of Float
12.7%
8.89%
Short % of Shares Outstanding
8.02%
6.30%
Days to Cover
4.65
5.13

Stock price statisticsIndustry

52-Week High
$10.00
–
52-Week Low
$1.27
–
20-Day Moving Average
$1.79
–
50-Day Moving Average
$2.30
–
200-Day Moving Average
$3.24
–
Average True Range (14)
$0.24
–
Price Change (1 Week)
9.49%
-7.83%
Price Change (1 Month)
-35.1%
-6.48%
Price Change (3 Months)
-44.6%
-26.6%
Price Change (6 Months)
-48.1%
-22.2%
Price Change (YTD)
-81.0%
-25.6%
Price Change (1 Year)
-80.5%
-23.8%
Price Change (3 Years)
-84.8%
-32.9%
Price Change (5 Years)
-95.0%
-77.3%
Price Change (10 Years)
-100.0%
-66.7%
Average Volume (10 Days)
2M
–
Average Volume (20 Days)
984,324
–
Average Volume (90 Days)
473,226
–
Relative Volume
0.74
0.86
Relative Strength Index (14)
35.3
40.3
Volatility (1 Year)
121.7%
80.5%

MarginsIndustry

Operating Margin
-9407.0%
-42.9%
Profit Margin
-9160.9%
-39.9%
EBITDA Margin
-9407.0%
-29.3%

Returns on capitalIndustry

Return on Equity (ROE)
-107.6%
-53.5%
Return on Assets (ROA)
-94.7%
-40.7%

GrowthIndustry

Revenue Growth (YoY)
-95.7%
5.68%

EfficiencyIndustry

Asset Turnover
0.01
0.39
Revenue Per Employee
$22.09K
$405.05K
Profits Per Employee
-$2.02M
-$704.12K
Employee Count
15
75

Income statement (TTM)Industry

Revenue
$331.30K
$58.79M
Operating Income
-$31.16M
-$21.49M
Net Income
-$30.35M
-$22.47M
EBITDA
-$31.16M
-$17.14M
EPS (Diluted)
-$3.21
-$0.83

Balance sheetIndustry

Net Cash (Debt)
$24.90M
$15.31M
Net Cash Per Share
$1.65
$0.72
Equity (Book Value)
$22.96M
$49.40M
Book Value Per Share
$1.52
$1.45
Tangible Book Value
$22.96M
$23.58M

Cash flow (TTM)Industry

Operating Cash Flow
-$27.98M
-$12.17M

Dividends and yieldsIndustry

Earnings Yield
-133.8%
-22.8%

Scores and fair valueIndustry

Altman Z-Score
-5.50
0.12
Piotroski F-Score
1
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?